Deal Announcements

ChanRx Collects New Venture Capital Investment

Tuesday, November 22, 2011 5:55:00 AM PDT | VentureDeal Staff

Garfield Heights, Ohio  --  Biotechnology company ChanRx (no website) has received an undisclosed amount of series A financing, according to a company statement.

ChanRx is developing small molecule drugs to treat atrial fibrillation.

The investment was from Sante Ventures and company founder, Dr. Arthur Brown.

The company said it would use the financing to "further evaluate the safety and efficacy of its proprietary AFIB drug, vanoxerine."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1